Verrica Pharmaceuticals Inc (NASDAQ:VRCA) shares, rose in value on Friday, July 11, with the stock price down by -7.55% to the previous day’s close as strong demand from buyers drove the stock to $0.81.
Actively observing the price movement in the last trading, the stock closed the session at $0.87, falling within a range of $0.7765 and $0.895. The value of beta (5-year monthly) was 1.758. Referring to stock’s 52-week performance, its high was $8.98, and the low was $0.38. On the whole, VRCA has fluctuated by 34.21% over the past month.
With the market capitalization of Verrica Pharmaceuticals Inc currently standing at about $74.60 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 19.62M, with a low estimate of 3M and a high estimate of 5.1M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.37M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VRCA’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of VRCA currently trading nearly 21.04% and 35.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.84, while the 7-day volatility ratio is showing 17.98% which for the 30-day chart, stands at 13.09%. Furthermore, Verrica Pharmaceuticals Inc (VRCA)’s beta value is 1.92.
A comparison of Verrica Pharmaceuticals Inc (VRCA) with its peers suggests the former has fared considerably weaker in the market. VRCA showed an intraday change of -7.55% in last session, and over the past year, it grew by 15.23%%.
Data on historical trading for Verrica Pharmaceuticals Inc (NASDAQ:VRCA) indicates that the trading volumes over the past 10 days have averaged 1.3 and over the past 3 months, they’ve averaged 420.63K. According to company’s latest data on outstanding shares, there are 91.79 million shares outstanding.
Nearly 45.85% of Verrica Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 32.25% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.97 million shares as on 2025-06-13, resulting in a short ratio of 10.78. According to the data, the short interest in Verrica Pharmaceuticals Inc (VRCA) stood at 578.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 3.15 million. The stock has fallen by -89.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VRCA stock heading into the next quarter.
